Paediatrics
Paediatrics

Cost-effectiveness of 15-valent or 20-valent pneumococcal conjugate vaccine for U.S. adults aged 65 years and older and adults 19 years and older with underlying conditions

Vaccine. 2024 Dec 6:126567. doi: 10.1016/j.vaccine.2024.126567. Online ahead of print. ABSTRACT BACKGROUND: In June 2021, the Advisory Committee on Immunization Practices (ACIP) recommended use of …